Similar articles for PMID: 9140390

Year	Number of Results
1984	1
1995	1
1996	5
1997	4
1998	5
1999	4
2000	15
2001	9
2002	3
2003	4
2004	2
2006	2
2011	1
2012	1
2014	1
2017	2
2018	2
2019	1
2020	1
2022	1
2024	0

1

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.

Ozçelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, Gallinger S, Redston M. Ozçelik H, et al. Nat Genet. 1997 May;16(1):17-8. doi: 10.1038/ng0597-17. Nat Genet. 1997. PMID: 9140390 No abstract available.

2

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE. Goggins M, et al. Cancer Res. 1996 Dec 1;56(23):5360-4. Cancer Res. 1996. PMID: 8968085

3

Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.

Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E. Shiri-Sverdlov R, et al. Hum Mutat. 2000 Dec;16(6):491-501. doi: 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.0.CO;2-J. Hum Mutat. 2000. PMID: 11102978

4

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.

Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E. Figer A, et al. Br J Cancer. 2001 Feb;84(4):478-81. doi: 10.1054/bjoc.2000.1605. Br J Cancer. 2001. PMID: 11207041 Free PMC article.

5

Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.

Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ. Tobias DH, et al. Gynecol Oncol. 2000 Aug;78(2):148-51. doi: 10.1006/gyno.2000.5848. Gynecol Oncol. 2000. PMID: 10926794

6

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.

Chen-Shtoyerman R, Figer A, Fidder HH, Rath P, Yeremin L, Bar Meir S, Friedman E, Theodor L. Chen-Shtoyerman R, et al. Br J Cancer. 2001 Feb;84(4):475-7. doi: 10.1054/bjoc.2000.1598. Br J Cancer. 2001. PMID: 11207040 Free PMC article.

7

High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.

Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E. Beller U, et al. Gynecol Oncol. 1997 Nov;67(2):123-6. doi: 10.1006/gyno.1997.4844. Gynecol Oncol. 1997. PMID: 9367693

8

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E. Vazina A, et al. Br J Cancer. 2000 Aug;83(4):463-6. doi: 10.1054/bjoc.2000.1249. Br J Cancer. 2000. PMID: 10945492 Free PMC article.

9

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.

Díez O, Osorio A, Robledo M, Barroso A, Domènech M, Cortés J, Albertos J, Sanz J, Brunet J, SanRomán JM, Alonso MC, Baiget M, Benítez J. Díez O, et al. Br J Cancer. 1999 Mar;79(7-8):1302-3. doi: 10.1038/sj.bjc.6690208. Br J Cancer. 1999. PMID: 10098775 Free PMC article.

10

Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.

Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing JP, Modan B. Fishman A, et al. Gynecol Oncol. 2000 Oct;79(1):74-8. doi: 10.1006/gyno.2000.5895. Gynecol Oncol. 2000. PMID: 11006035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year